TY  - GEN
AU  - Tanigawara,Y
AU  - Aoyama,N
AU  - Kita,T
AU  - Shirakawa,K
AU  - Komada,F
AU  - Kasuga,M
AU  - Okumura,K
TI  - CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori
SN  - 0009-9236
PY  - 1999///1206
KW  - Amoxicillin
KW  - therapeutic use
KW  - Antacids
KW  - Anti-Bacterial Agents
KW  - Anti-Ulcer Agents
KW  - pharmacology
KW  - Aryl Hydrocarbon Hydroxylases
KW  - Bismuth
KW  - Clarithromycin
KW  - Cytochrome P-450 CYP2C19
KW  - Cytochrome P-450 Enzyme Inhibitors
KW  - Cytochrome P-450 Enzyme System
KW  - genetics
KW  - Drug Therapy, Combination
KW  - Enzyme Inhibitors
KW  - Gastritis
KW  - drug therapy
KW  - Genotype
KW  - Helicobacter Infections
KW  - Helicobacter pylori
KW  - drug effects
KW  - Histamine H2 Antagonists
KW  - Humans
KW  - Metronidazole
KW  - Mixed Function Oxygenases
KW  - antagonists & inhibitors
KW  - Omeprazole
KW  - Penicillins
KW  - Peptic Ulcer
KW  - Polymerase Chain Reaction
KW  - Polymorphism, Restriction Fragment Length
KW  - Protein Synthesis Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S0009-9236(99)70017-2
ER  -